Main Analytical Methods for the Viability Assessment of Mesenchymal Stem Cells for Use as Cellular Medicines

被引：4
|
作者：
Galocha-Leon, Cristina [1 ]
Clares-Naveros, Beatriz [1 ]
Galvez-Martin, Patricia [1 ,2 ]
机构：
[1] Univ Granada, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-18071 Granada, Spain
[2] Bioiberica SAU, Adv Therapies Area, E-08029 Barcelona, Spain
来源：
CURRENT PHARMACEUTICAL ANALYSIS | 2018年 / 14卷 / 05期
关键词：
Mesenchymal stem cells; cell therapy; cell viability; cell count; analytical methods; quality control assays; FLUORESCENT-PROTEIN BIOSENSORS; TRYPAN BLUE; CYTOTOXICITY; GROWTH; SYSTEM; ASSAYS; TOOLS;
D O I：
10.2174/1573412913666170613090734
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background: Mesenchymal Stem Cells (MSCs) are multipotent stem cells with therapeutic potential in advanced therapies and regenerative medicine. Currently, MSCs are being widely studied as cellular medicine. In the design and development of medicines with cells, the study of viability is an important quality control requirement. Objective: Description of the main analytical techniques to study the MSCs viability as cellular medicine. Results: The cellular medicine must contain viable cells, for its use in vivo the cell viability must be at least greater or equal to 80%. Therefore, the study of cell viability of MSCs during its ex vivo expansion and its final formulation is a prerequisite before being administered. Conclusion: In this review the main analytical techniques based on studies of the cell membrane integrity, morphological assays and fluorescence biosensors are described. All of them are approved for use in quality control programs for clinical use of MSCs.
引用
收藏
页码：427 / 436
页数：10
相关论文
共 50 条
  • [41] Production of mesenchymal stem cells in clinical use
    Bourin, Philippe
    Sensebe, Luc
    HEMATOLOGIE, 2005, 11 (06): : 373 - 383
  • [42] Prospects of the Use of Mesenchymal and Neuromesenchymal Stem Cells
    Rybachuk, O. A.
    Pivneva, T. A.
    NEUROPHYSIOLOGY, 2013, 45 (5-6) : 477 - 494
  • [43] Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
    Dupuis, Victoria
    Oltra, Elisa
    WORLD JOURNAL OF STEM CELLS, 2021, 13 (08): : 1094 - 1111
  • [44] Mesenchymal Stem Cells as Cellular Immunotherapeutics in Allogeneic Hematopoietic Stem Cell Transplantation
    Papewalis, Claudia
    Topolar, Daniela
    Goetz, Barbara
    Schoenberger, Stefan
    Dilloo, Dagmar
    MESENCHYMAL STEM CELLS: BASICS AND CLINICAL APPLICATION II, 2013, 130 : 131 - 162
  • [45] Sensitivity of mesenchymal stem cells and their progeny to medicines used for the treatment of hematoproliferative diseases
    Nifontova, Irina
    Svinareva, Daria
    Petrova, Tatiana
    Drize, Nina
    ACTA HAEMATOLOGICA, 2008, 119 (02) : 98 - 103
  • [46] Real-time quality control and functional assessment of mesenchymal stem cells for cellular therapies.
    Guimet, D.
    Abassi, Y.
    Jin, C.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [47] Cellular aging of mesenchymal stem cells - A continuous and organized process
    Horn, Patrick
    Castoldi, Mirco
    Bork, Simone
    Diehlmann, Anke
    Saffrich, Rainer
    Benes, Vladimir
    Blake, Jonathan
    Eckstein, Volker
    Ho, Anthony D.
    Wagner, Wolfgang
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (07) : S81 - S81
  • [48] Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells
    Pandey, Amitabh C.
    Lancaster, Jordan J.
    Harris, David T.
    Goldman, Steven
    Juneman, Elizabeth
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [49] The secretome of mesenchymal stem cells and regenerative cellular therapy in cancer
    Ascencio Gonzalez, Daniel
    Ochoa Carrillo, Francisco Javier
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 (06): : 329 - 331
  • [50] Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases
    Ding, Suet Lee Shirley
    Kumar, Suresh
    Mok, Pooi Ling
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
12345